Health Technology/clinical-trials

Large-Scale Smartwatch Intervention Trial Targets Cardiovascular Risk in Pre-Disease States — 1,400 Participant Study

247 Health News Editorial

·

7 Apr 2026

·

4 min read

·clinical-trials

A large-scale Chinese trial is testing whether smartwatch-based interventions can prevent cardiovascular disease in 1,400 overweight individuals with pre-disease conditions. The study targets the critical window before hypertension, diabetes, and dyslipidemia develop.

Originally reported by ClinicalTrials.gov

References

  1. 1.Beijing Anzhen Hospital. (2024). A Smart Wearable Devices-based Comprehensive Intervention Through a Cluster Randomized Controlled Trial to Improve Cardiovascular Health in Overweight/Obese Individuals With Cardiometabolic Preconditions. ClinicalTrials.gov. NCT07372729. https://clinicaltrials.gov/study/NCT07372729
  2. 2.Lloyd-Jones, D. M., Allen, N. B., Anderson, C. A., Black, T., Brewer, L. C., Foraker, R. E., Grandner, M. A., Lavretsky, H., Perak, A. M., Sharma, G., & Rosamond, W. (2022). Life's Essential 8: Updating and Enhancing the American Heart Association's Construct for Cardiovascular Health. Circulation, 146(5), e18-e43. https://doi.org/10.1161/CIR.0000000000001078
  3. 3.Cadmus-Bertram, L. A., Marcus, B. H., Patterson, R. E., Parker, B. A., & Morey, B. L. (2015). Randomized trial of a Fitbit-based physical activity intervention for women. American Journal of Preventive Medicine, 49(3), 414-418. https://doi.org/10.1016/j.amepre.2015.01.020
  4. 4.Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., Bonny, A., Brauer, M., Brodmann, M., Cahill, T. J., Carapetis, J., Catapano, A. L., Chugh, S. S., Cooper, L. T., Coresh, J., ... Fuster, V. (2020). Global burden of cardiovascular diseases and risk factors, 1990-2019. Journal of the American College of Cardiology, 76(25), 2982-3021. https://doi.org/10.1016/j.jacc.2020.11.010
  5. 5.Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I. M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., Nonas, C. A., Sacks, F. M., Smith, S. C., Svetkey, L. P., Wadden, T. A., & Yanovski, S. Z. (2014). 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. Circulation, 129(25 Suppl 2), S76-S99. https://doi.org/10.1161/01.cir.0000437740.48606.d1
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service